Details for Patent: 9,675,613
✉ Email this page to a colleague
Which drugs does patent 9,675,613 protect, and when does it expire?
Patent 9,675,613 protects MITIGARE and is included in one NDA.
Summary for Patent: 9,675,613
| Title: | Methods of colchicine administration |
| Abstract: | The invention provides improved methods for coadministration of colchicine with drugs metabolized by CYP3A4 (anciently referred to as cytochrome P450 isozyme 3A4) or the P-glycoprotein transporter, but not both. The method enables non-toxic coadministration of colchicine and the second drug at their ordinary levels safely and effectively without reducing the dose or frequency for either drug. |
| Inventor(s): | Ducharme; Murray (St. Laurent, CA) |
| Assignee: | Hikma Pharmaceuticals LLC (JO) |
| Application Number: | 14/511,703 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,675,613 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 9,675,613
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma Intl Pharms | MITIGARE | colchicine | CAPSULE;ORAL | 204820-001 | Sep 26, 2014 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | METHOD OF USING COLCHICINE FOR THE PROPHYLAXIS OF GOUT FLARES | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
